<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">HALAZEPAM</span><br/>(hal-az'e-pam)<br/><span class="topboxtradename">Paxipam<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span>; <span class="classification">benzodiazepine</span><br/><b>Prototype: </b>Lorazepam<br/><b>Pregnancy Category: </b>D<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>20 mg, 40 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Psychotropic drug that shares antianxiety action of other short-term benzodiazepine derivatives. Effects (anxiolytic, sedative,
         hypnotic, and skeletal muscle relaxant) are mediated by the inhibitory neurotransmitter GABA.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Clinically it produces a dose-related CNS depressant effect ranging from mild improvement of psychomotor activity, decreased
         anxiety to sedative hypnotic effects.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>To manage anxiety disorders or for short-term relief of anxiety symptoms.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to halazepam or other benzodiazepines; psychosis, anxiety-free psychiatric disorders; acute narrow-angle
         glaucoma.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Abnormal kidney or liver function. Safe use during pregnancy (category D), lactation, or in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Anxiety</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2040 mg t.i.d. or q.i.d.<br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 20 mg 12 times daily<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li> 				Note: Patients with renal or hepatic impairment may require lower doses. Consult physician. 			</li>
<li>Store at 2°30° C (36°86° F) unless directed otherwise.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness, sedation,</span> headache, confusion, ataxia, paresthesia, motion sickness. <span class="typehead"> CV:</span> Hypotension, tachycardia, bradycardia. <span class="typehead">GI:</span> Dry mouth, increased salivation, nausea, vomiting, constipation, abnormal liver values. <span class="typehead">Special Senses:</span> Visual disturbances. <span class="typehead">Urogenital:</span> GU distress. <span class="typehead">Respiratory:</span> Respiratory disturbances. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Cimetidine,</b> <b>disulfiram,</b> <span class="classification">oral contraceptives</span> may increase effects of halazepam; <b>alcohol,</b> other <span class="classification">cns depressants</span> compound CNS depression. <span class="typehead"> Herbal:</span> <b>Kava-kava,</b> <b>valerian</b> may potentiate sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 13 h. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver to active form. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 30200 h (active metabolite). 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for adverse effects. Ataxia, confusion, or oversedation may be symptoms of overdosage and can occur at relatively
            low dosage in older adult or debilitated patient.
         </li>
<li>Reassess response to halazepam periodically.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Discuss with physician desirability of discontinuing drug because of its potential hazard to the fetus if you become or plan
            to become pregnant.
         </li>
<li>Do not stop taking drug suddenly. Barbiturate-like withdrawal symptoms may occur (dysphoria, insomnia, abdominal and muscle
            cramps, vomiting, sweating, tremors, convulsions).
         </li>
<li> 							Note: Smoking decreases sedative effects of halazepam. 						</li>
<li>Do not drive or engage in other potentially hazardous activities until response to drug is known.</li>
<li>Be aware that alcohol or other CNS depressants can produce additive effects.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>